Follow-up Monitoring of DR-TB Patients

The following points should be covered in follow-up monitoring of Drug-resistant TB (DR-TB) patients:

• Monitor DR-TB treatment progress and disease response.
• Monitor bacteriological and radiological improvements in DR-TB treatment.
• Identify derangements in bio-chemical results and on Electrocardiogram (ECG) which are indicative of systemic disorders that could result in drug-induced adverse events, or comorbidities that may require timely interventions to address and improve the probability of treatment success, survival and quality of life.
• Follow-up monitoring to be done periodically based on the type of TB/ severity of disease/ type of regimen used, etc.

Components of Follow-up Monitoring 

1. Clinical monitoring
2. Follow-up evaluations

Resources

• Guidelines for Programmatic Management of Drug-resistant Tuberculosis in India, March 2021.
• WHO Consolidated Guidelines on Tuberculosis: Module 4 - Treatment: Drug-resistant TB Treatment, 2020.

Kindly provide your valuable feedback on the page to the link provided HERE